An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects WithModerately to Severely Active Crohn's Disease Treated With VedolizumabIV - Effect of Vedolizumab IV on Mucosal Healing in Crohn's Disease An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects WithModerately to Severely Active ...